FactSet (NYSE: FDS) director Wiesel receives RSU and option grants

Rhea-AI Filing Summary

FactSet Research Systems Inc. director Shlomo Elisha Wiesel received new equity awards. On January 15, 2026, he was granted 571 shares of common stock in the form of restricted stock units at a price of $0, increasing his directly held common stock to 1,141 shares.

On the same date, he was also granted a non-employee director stock option covering 1,396 shares of common stock with an exercise price of $289.68 per share and a reported grant price of $0. Both the restricted stock units and the options cliff vest 100% on the first anniversary of the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wiesel Shlomo Elisha

(Last) (First) (Middle)

45 GLOVER AVENUE

(Street)

NORWALK CT 06850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FACTSET RESEARCH SYSTEMS INC [ FDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		A		571(1)	A	$0	1,141	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Employee Director Stock Option (right to buy)	$289.68	01/15/2026		A		1,396		01/15/2027(2)	01/15/2033	Common Stock	1,396	$0	1,396	D

Explanation of Responses:

1. Restricted stock units granted to non-employee Directors cliff vest 100% on the first anniversary of the date of grant.

2. Options granted to non-employee Directors cliff vest 100% on the first anniversary of the date of grant.

Remarks:

	/s/ WINNIFRED LEWIS, Attorney in Fact for S. Elisha Wiesel	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did FactSet (FDS) disclose for Shlomo Elisha Wiesel?

The filing reports that director Shlomo Elisha Wiesel received two equity awards on January 15, 2026: (1) 571 restricted stock units of FactSet common stock at $0, and (2) a non-employee director stock option for 1,396 shares of common stock with an exercise price of $289.68 per share and a grant price of $0.

How many FactSet (FDS) common shares does Shlomo Elisha Wiesel own after this Form 4?

After the reported restricted stock unit grant, Shlomo Elisha Wiesel beneficially owns 1,141 shares of FactSet common stock directly, according to the Form 4.

What are the vesting terms of the equity awards reported for FactSet (FDS) director Wiesel?

The 571 restricted stock units granted to the non-employee director cliff vest 100% on the first anniversary of the grant date. The 1,396 stock options granted to the non-employee director also cliff vest 100% on the first anniversary of the grant date.

What is the exercise price of the stock options granted to the FactSet (FDS) director?

The non-employee director stock option granted to Shlomo Elisha Wiesel covers 1,396 shares of FactSet common stock and has an exercise price of $289.68 per share, with a reported grant price of $0 for the derivative security.

When do the newly granted FactSet (FDS) director stock options expire?

The non-employee director stock option granted on January 15, 2026 becomes exercisable on January 15, 2027 and has an expiration date of January 15, 2033, as disclosed in the Form 4.

Is Shlomo Elisha Wiesel a director or officer of FactSet (FDS) in this filing?

In this Form 4, Shlomo Elisha Wiesel is identified as a director of FactSet Research Systems Inc. and is not listed as an officer or 10% owner.